Results 261 to 270 of about 40,633 (287)

Prognostic implication of DPD quantification in transthyretin cardiac amyloidosis. [PDF]

Eur Heart J Cardiovasc Imaging
Rettl R, Duca F, Kronberger C, Binder C, Willixhofer R, Ermolaev N, Poledniczek M, Hofer F, Nitsche C, Hengstenberg C, Eslam RB, Kastner J, Bergler-Klein J, Hacker M, Calabretta R, Kammerlander AA.   +15 more
europepmc   +1 more source

A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital. [PDF]

Front Cardiovasc Med
López-Ponce de León JD, Granados-Álvarez S, Arango-Ibanez JP, Montero Echeverri JM, Arteaga Tobar AA, Garcia AF, Rodas Cortes Y, Gómez-Mesa JE.   +7 more
europepmc   +1 more source

Multimodality imaging of cardiac amyloidosis. [PDF]

Heart
Benz DC, Dorbala S.
europepmc   +1 more source

Echocardiographic Features of Wild-Type Transthyretin Cardiac Amyloidosis From J-Case: Multicenter Survey in Japan. [PDF]

JACC Asia
Kitada S, Kawada Y, Shintani Y, Yamamoto J, Kikuchi S, Usuku H, Tsujita K, Ochi Y, Kubo T, Motoki H, Iwano H, Watanabe T, Ohte N, Seo Y.   +13 more
europepmc   +1 more source

Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review. [PDF]

J Am Heart Assoc
Grogan M, Lopez-Jimenez F, Guthrie S, Kumar N, Langevin R, Lousada I, Witteles R, Royyuru A, Rosenzweig M, Cairns-Smith S, Ouyang D.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cardiac amyloidosis

Current Treatment Options in Cardiovascular Medicine, 1999
No definitive therapy is available for cardiac amyloidosis. Treatment with alkylating agents such as melphalan has improved survival. Patients who do not respond to melphalan have benefited from high-dose chemotherapy with cyclophosphamide followed by peripheral stem cell transplantation.
Jeffrey D. Hosenpud, Kiran Kashyap
openaire   +3 more sources

Cardiac amyloidosis

Clinical and Translational Imaging, 2019
Purpose: The aim of the present article was to review the recent developments in diagnosis, prognostication and management of cardiac amyloidosis. Methods: Available scientific literature on cardiac amyloidosis has been critically reviewed. Results: Different precursors cause different forms of cardiac amyloidosis with different outcomes and ...
Giorgetti, Assuero, Genovesi, Dario, Milan, Elisa, Acampa, Wanda, Giubbini, Raffaele, Cuocolo, Alberto, Marzullo, Paolo   +6 more
openaire   +2 more sources